Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)ca… Grant US-11833248-B2 United States of America 05 Dec 2023
Compositions of GLP-1 peptides and preparation thereof Grant US-11759503-B2 United States of America 19 Sep 2023
Compositions of GLP-1 peptides and preparation thereof Grant US-11759502-B2 United States of America 19 Sep 2023
Compositions of GLP-1 peptides and preparation thereof Grant US-11759501-B2 United States of America 19 Sep 2023
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)ca… Grant US-11382957-B2 United States of America 12 Jul 2022
Methods and compositions for oral administration Grant US-11246827-B2 United States of America 15 Feb 2022
Compositions comprising a delivery agent and preparation thereof Grant US-11123296-B2 United States of America 21 Sep 2021
Tablet formulation comprising a GLP-1 peptide and a delivery agent Grant US-11033499-B2 United States of America 15 Jun 2021
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino… Grant US-10960052-B2 United States of America 30 Mar 2021
Compositions of GLP-1 peptides and preparation thereof Grant US-10933120-B2 United States of America 02 Mar 2021
SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2- HYDROXYBENZOYL)AMINO)C… Grant EP-3326620-B1 European Patent Office 04 Mar 2020
Methods and compositions for oral administration Grant US-10420721-B2 United States of America 24 Sep 2019
Compositions comprising a delivery agent and preparation thereof Application US-10335369-B2 United States of America 02 Jul 2019
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)ca… Application US-10086047-B2 United States of America 02 Oct 2018
Methods and compositions for oral administration Grant US-10010503-B2 United States of America 03 Jul 2018
Tablet formulation comprising semaglutide and a delivery agent Application US-9993430-B2 United States of America 12 Jun 2018